Health

(READ) ‘Uniquely complicated course’ for patient treated with controversial new Alzheimer’s drug: aducanumab

The following is an excerpt from Medpage Today. A man treated with the recently approved Alzheimer’s drug aducanumab (Aduhelm) had six amyloid-related imaging abnormality (ARIA) episodes, researchers reported. Over 44 months in a long-term extension study, the Alzheimer’s disease patient

(READ) ‘Uniquely complicated course’ for patient treated with controversial new Alzheimer’s drug: aducanumab Read More »

(READ) Exclusive: “Increased number” of Covid-19 vaccine injury claims from govt. employees

In the face of the Biden administration’s Covid-19 vaccine mandate for federal employees and contractors, the government reports it’s already getting “an increased number of claims resulting from apparent adverse reactions to the COVID-19 vaccination.” Normally, vaccine injuries are not

(READ) Exclusive: “Increased number” of Covid-19 vaccine injury claims from govt. employees Read More »

Republicans question US govt. experimentation on “dangerous pathogens”

Oversight Committee Republican James Comer (R-Kentucky) and Sen. Roger Marshall (R-Kansas) are questioning an agreement between the U.S. Agency for International Development (USAID) and Washington State University (WSU) that reportedly involves “dangerous research on human pathogens.” Considering the recent lack

Republicans question US govt. experimentation on “dangerous pathogens” Read More »

Scroll to Top